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Background: Malaria is one of the most important parasitic diseases in the world. It remains a major public health 
problem in Africa and is responsible for the annual death of over one million children below the age of five years. The 
Plasmodium falciparum is the most widespread etiological agent for human malaria and has become increasingly 
resistant to standard antimalarial drugs. Therefore, this necessitates a continuous effort to search for new drugs, 
particularly with novel modes of action. The medicinal plants have invariably been a rich source for new drugs and 
some antimalarial drugs in use today (quinine and artemisinin) were either obtained from plants or developed using 
their chemical structures as templates. 
Objective: The aim of the study was to screen seven selected medicinal plants from Kenya for antimalarial activity. 
Materials and methods: Twenty one (21) extracts from seven plants: C. myricoides, C. abyssinica, A. racemosus, A. 
remota, C. edulis, S. princeae and L. calostachys were selected for in vitro antimalarial screening out of which 10 
extracts with good activity in vitro were tested further in a mouse model. In vitro antiplasmodial testing was done by 
measuring ability of the test sample to inhibit the incorporation of radio-labelled hypoxanthine into the malaria 
parasite. In vivo bioassay was done in mice using Peter’s 4-days suppressive test. 
Results: From the results achieved, 10 out of the 21 extracts tested, exhibited antiplasmodial activity, with IC50 values 
ranging from 6.93μg/ml to 88.4μg/ml. when tested in vivo one of the extracts had high activity with 
chemosuppression of 82.17%, while the rest ranged between 39.93% and 61.86%. 
Conclusions: The activities observed especially with the methanol extracts indicate that these plants deserve to be 
investigated further as potential antimalarial agents. 
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1. Introduction 
Malaria is one of the major threats concerning world 
public health. There are around 250 million clinical 
cases every year and almost one million deaths, mostly 
children, which are attributable to this disease (WHO, 
2008). The main reasons that explain this worsening 
situation are therapy problems: resistance to the 
current antimalarial drugs, unavailability and 
unaffordability of antimalarial drugs and lack of new 
therapeutic targets (Muregi et al, 2003). Plants have 
invariably been a rich source for new drugs and some 
antimalarial drugs in use today (quinine and 
artemisinin) were either obtained from plants or 
developed using their chemical structures as templates 
(Gessler et al, 1994). It is already estimated that 122 
drugs from 94 plant species have been discovered 
through ethnobotanical leads (Fabricant and 
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Farnsworth, 2001). Plants commonly used in traditional 
medicine are assumed to be safe due to their long usage 
in the treatment of diseases according to knowledge 
accumulated over centuries. Therefore, the search for 
new drugs through the evaluation and validation of 
traditional medicines offers a good opportunity for the 
discovery and development of better medicines. Today, 
many pharmacological classes of drugs contain a 
natural product prototype. Morphine one of the best 
painkillers was isolated from Papaver somniferum, 
aspirin an analgesic and anticoagulant from the willow 
bark, warfarin an anticoagulant from Melilotus 
officinalis, Metformin the current gold standard for 
management of type 2 diabetes from Galega officinalis, 
quinine from Cinchona ledgeria and artimesinin 
currently the most potent antimalarial drug from 
Artemisia annua (Gilani and Rahman, 2005, Bailey et al, 
2007, Gathirwa et al, 2011). Similarly, the in vivo 
antimalarial properties of several plant extracts have 
been studied in mice (Andrade-Neto et al, 2003). 
Following this trend, this study presents the results 
obtained from the evaluation of the in vitro and in vivo 
antiplasmodial activity of seven medicinal plants 
namely: C. myricoides, C. abyssinica, A. racemosus, A. 
remota, C. edulis, S. princeae and L. calostachys. The 
seven medicinal plants were selected on the basis of 
their traditional reputation to treat fevers or malaria 
locally by Nandi community in Kenya. Cytotoxicity on 
human fibroblasts was also evaluated in order to 
determine the selectivity of antimalarial action. 
2. Materials and Methods 
2.1 Plant collection and preparation 
The seven medicinal plants were selected on the basis 
of their traditional reputation to treat fevers or malaria 
locally. The plants were collected in Aldai division, 
Nandi County in March 2006. Permission for a 
sustainable plant harvesting was obtained from the 
Kenya Wildlife Services in the forest reserves, and from 
the local communities outside the forest area. The plant 
specimens were identified and authenticated and 
voucher specimens deposited at the Botanical Garden 
Herbarium of Maseno and East African Herbarium, 
National Museum of Kenya. C. myricoides 
(PJ/AL/03/06/01), C. abyssinica (PJ/AL/03/06/02), A. 
racemosus (PJ/AL/03/06/03), A. remota 
(PJ/AL/03/06/04), C. edulis (PJ/AL/03/06/05), S. 
princeae (PJ/AL/03/06/06), and L. calostachys 
(PJ/AL/03/06/07) 
The plant parts were air-dried at room temperature 
under shade for 14 days and pulverized using a 
laboratory mill (Christy & Norris Ltd., Chelmsford, 
England) at the Center for Traditional Medicine and 
Drug Research, Kenya Medical Research Institute. The 
resulting powders were packed in air tight polythene 
bags, labeled and stored in the dark until used. 
2.2 Plant Extraction 
The plant material (50g) was extracted at room 
temperature with chloromethane and methanol for 24 
hours each. The resulting extracts were filtered and 
concentrated under reduced pressure in vacuo to yield 
chloromethane extract and methanol extract 
Another 50 g of the same sample was extracted once 
with 500 ml of distilled water in a water bath at 60 °C 
for 1 h, filtered and lyophilized in a freeze dryer. 
The dry extracts for all the samples similarly treated 
were weighed into airtight containers and stored at 4 °C 
until used. 
2.3 In vitro antiplasmodial testing 
The Sierra Leonean CQ sensitive (D6) and Indochinese 
CQ-resistant (W2) Plasmodium falciparum strains were 
used in the study. The parasite cultures were donated 
by the Malaria Research and Reference Reagent 
Resource Center (MR4), Manassas, Virginia, USA. 
Parasite cultivation was carried out using previously 
described procedures (Trager and Jensen, 1976; 
Schlichtherle et al, 2000). Cultures were maintained in 
RPMI 1640 culture medium (10.4 g/l) powdered 
medium without PABA and lactic acid (LA) dissolved in 
960 ml of double distilled autoclaved water (DDAW), 
supplemented with 10% human serum, 25mM (5.94 
g/l) HEPES and 25mM NaHCO3. Human O+ red blood 
cells served as the parasites host cells. Test samples 
were prepared by dissolving in 100% Dimethyl 
sulfoxide (DMSO) and diluting in RPMI to lower the 
concentration of DMSO to ≤1%. Stock solution (1µg/ml) 
of chloroquine was also prepared for use as the 
reference drug. Semi-automated micro dilution assay 
technique that measures the ability of the extracts to 
inhibit the incorporation of [G-3H] hypoxanthine 
(Amersham International, Burkinghamshire, UK) into 
the malaria parasite was used in testing antiplasmodial 
activity (Desjardins et al, 1979). Aliquots (50µl) of the 
test solutions were added in the first wells of 96 well 
flat bottomed micro culture plates (Costar Glass Works, 
Cambridge, UK) in duplicate and serial diluted down the 
plate using a Titertek motorized hand diluter (Flow 
Laboratories, Uxbridge, UK). The last row of wells did 
not contain the test samples and served as the controls. 
Two hundred microliters of malaria parasite culture 
was added into each well. The set plates were incubated 
at 37 OC in a gas mixture 3% CO2, 5% O2 and 92% N2 for 
48 h, after which each well was pulsed with 25µl of 
culture medium containing 0.5µCi of [G-3H] 
hypoxanthine. The plates were incubated for a further 
18 hours. The contents of each well were then 
harvested onto glass fiber filter mats, washed 
thoroughly with distilled water, dried and the 
radioactivity in counts per minute (cpm) measured 
using a beta-counter (Wallac Micro Beta Trilux). The 
cpms obtained were then used to compute the IC50 
values as described by Sixsmith et al, (1984). 
2.4 In vivo antimalarial testing  
Male albino mice (6–8 weeks old, weighing 20±2 g) 
were used in the experiment. The mice were housed in 
standard macrolon type II cages in air-conditioned 
rooms at 22 °C, 50–70% relative humidity, fed with the 
standard diet and received water ad libitum. 
Plasmodium berghei strain ANKA was maintained by 
serial passage of infected blood through interperitonial 
injection (ip). The test protocol was based on the 4-day 
suppressive test (Peters et al, 1975). Briefly, P. berghei 
infected blood was obtained by heart puncture, mixed 
with 1% (w/v) heparin in phosphate buffered saline 
(PBS) (1:1) and the test animals infected by ip injection 
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with 0.2 ml (1×107 parasitized erythrocytes). Infected 
mice were randomly selected into groups of five for one 
test sample and the experimental groups treated with a 
single dose of 800 mg/kg of the test sample in 0.2 ml by 
oral adminstration from day 0 (immediately after 
infection) to day 3 (Gessler et al, 1995). The mice in the 
positive control group were given chloroquine 
diphoshate (dissolved in 10% tween 80) at 5 
mg/kg/day orally. Those in the negative control group 
received the placebo (10% tween 80) at 0.2 ml/kg/day. 
Parasitaemia was determined on day 4 (24 h after the 
last treatment) by microscopic examination by counting 
parasites in 4 fields of ≈100 erythrocytes per view of 
thin blood film sampled from the tail of the 
experimental mouse and stained in 10% giemsa 
solution. The difference between the mean number of 
parasites per view in the negative control group (100%) 
and those of the experimental groups was calculated 
and expressed as percent parasitaemia suppression 
(chemo suppression) (Tona et al, 2001). Where, A is the 
mean parasitaemia in the negative control on day 4, and 
B the corresponding parasitaemia in the test group. All 
in vivo experiments were repeated three times. In cases 
where the standard deviation (SD) was large, the 
experiment was repeated yet again and in some 
instances, outliers were not considered while 
computing the SD. Percentage parasitaemia was 
described as number of parasitized erythrocytes per 
100 erythrocytes while percentage chemo suppression 
was taken as inhibition of parasite growth / 
multiplication relative to control expressed in 
percentage. Parasites in the negative control group 
were assumed to have experienced 0% chemo-
suppression. Chemo suppression is thus the potency of 
the drug to inhibit parasite growth/multiplication. 
2.5 Ethical Considerations 
In this study, all the animal experiments were 
performed according to the guidelines of the KEMRI 
Animal Care and Use Committee, (ACUC). Approval was 
obtained from the KEMRI-ACUC for the use of 
laboratory animals. 
 
 Table1. The mean IC50 values (X ± SD) for plants extracts against Plasmodium falciparum D6 µg/mL 
Plant species  Plant part Extract IC50 (µg/mL) D6 
C. myricoides  Leaves Chloroform >100 
Methanol              19.96 
Water >100 
C. myricoides  Rootbark Chloroform >100 
Methanol              10.2 
Water >100 
L. calostachys  Leaves Chloroform 40.2 
Methanol              88.4 
Water >100 
A. racemosus Leaves Chloroform >100 
Methanol              31.35 
Water >100 
C. abbysinica  Leaves Chloroform >100 
Methanol              26.72 
Water >100 
C. abbysinica  Roots Chloroform >100 
Methanol              6.93 
Water 66.52 
A. remota Leaves Chloroform >100 
Methanol              22.1 
Water >100 
C. edulis Roots Chloroform >100 
Methanol              >100 
Water >100 
S. princeae Roots Chloroform >100 
Methanol              >100 
Water >100 
Chloroquine (CQ)   0.020 
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3.  Results 
3.1 In vitro anti-plasmodial assays 
The in vitro activities of L. calostachys, A. remota and A. 
racemosus were within the mild activity range (20-
100µg/ml). A. remota and A. racemosus had only its 
methanol extracts showing good activity (IC50=22.1 and 
31.35 µ g/ ml) – Table 1. 
S. princeae and C edulis showed no reasonable in-vitro 
activity against D6 for all the extracts (IC50 >100 µg/ml). 
Apart from chloroform and aqueous extracts of A. 
racemosus that showed no activity, methanol extracts 
was within the mild activity range. 
For A. remota, only the methanol extracts showed mild 
activity of IC50 =22.1 µg/mL whereas the rest were 
inactive. Methanolic extracts of leaves and rootbark of C. 
myricoides showed good activity against the two 
isolates used. C. abyssinica methanolic   extracts for both 
roots and leaves exhibited reasonable antiplasmodial 
activity (IC50=6.93 and 26.72 ug/mL). Ajuga methanolic 
extracts also exhibited reasonable anti-plasmodial 
activity (IC 50=22.1 ug/ml). 
The Clerodendrum myricoides showed good anti-
plasmodial activity of the methanolic extract. Although 
the root bark lacked activity in most of the extracts, the 
methanolic one gave high activity (IC50 = 10.2 µg/ml for 
D6 and 9.96 µg/ml for W2 respectively which is twice as 
active as that of the leaves IC50 =19.96 and 20.58µg/ml 
(Table 2). This is an indication of a better in-vivo 
antiplasmodial activity of the root bark than that of the 
leaves. There are cases in which the chloroquine-
resistant isolates seemed to be more responsible to the 
plant extracts than the susceptible ones. For example, 
W2 is more than two times susceptible than D6 to C. 
abyssinica leaves methanolic extracts (IC50=12.22 and 
26.72 µg/ml, respectively). 
3.2 In vivo antiplasmodial activity 
Methanol extracts giving optimum antiplasmodial 
activity in vitro were subjected to further investigation 
in mice for antimalarial potential. Table 3 summarizes 
the the in vivo antimalarial activity of the selected plant 
extracts. 
It was found that C. abbyssinica, A. racemosus and C. 
myricoides plants used by traditional healers in Nandi 
district to treat malaria exhibited good in vivo 
antiplasmodial activity. The methanol extracts are the 
most active.  
The chemosuppresion increased gradually from day 2 
to day 4. From the chemo suppression data, it shows 
that parasite clearance was much pronounced on the 
fourth day. 
 
Table 2: The mean IC50 values (X± SD) for selected plants extracts against chloroquine-sensitive (D6) and 
chloroquine-resistant (W2) P. falciparum isolates 
Plant species  Plant part Extract 
IC50 (µg/mL) D6 
(Chloroquine 
sensitive) 
IC50 (µg/mL) W2 
(Chloroquine 
resistant) 
C. myricoides  Leaves Methanol              19.96 20.58 
C. myricoides  Rootbark Methanol              10.2 9.96 
C. abbysinica  Roots Methanol              6.93 12.22 
Chloroquine    0.020 0.069 
 
 
Table 3: In vivo anti-malarial activity of selected medicinal plant extracts on Plasmodium berghei in mice 
Plant species  Plant part Extract Parasite Density Chemo-Suppression (%) 
Clutia abbysinica  Leaves Methanol             24.03% 42.10% 
Clutia abbysinica  Roots Methanol             24.93% 39.93% 
Asparagus racemosus  Leaves Methanol             19.07% 54.05 % 
Clerodendrum myricoides  Leaves Methanol             7.4% 82.17% 
Clerodendrum myricoides  Roots Methanol             15.83% 61.86% 
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4. Discussion 
In vitro anti-plasmodial assays, In vivo antiplasmodial 
activity and chemo-suppression results indicated that 
methanol extracts were very effective compared to 
chloroform and water extracts. This would be attributed 
to the fact that methanol extracts contained many of the 
bioactive compounds from the plant materials which 
acts on the plasmodia parasites. The major ingredients 
known to occur in most medicinal plants are the 
alkaloids, terpenoids and flavonoids, whose presences 
is attributed to the antimicrobial activity in plants 
(Nostros et al, 2000). The concentrations and 
proportions of the active compounds in plant extracts 
components depend on the plant variety, origin, time of 
harvest, solvent used, conditions of processing and 
storage (Deans and Ritchie 1987). This agrees with the 
ethnobotanical uses of the plants among the people of 
Aldai Division of Nandi County (Jeruto et al, 2008).  
The methanolic root extract of Clerodendrum myricoides 
showing good anti-plasmodial activity  for both D6 (IC50 
= 10.2 µg/ml) and W2 (9.96 µg/ml) is supported by the 
fact that root bark act as reservoirs for photosynthates 
or exudates (Balick and Cox, 1996) hence containing 
many phytochemicals whose presences is attributed to 
the antiplasmodial activity in plants. In cases in which 
the chloroquine resistant isolates seemed to be more 
responsive to the plant extracts than the susceptible 
ones, it suggests lack of cross-resistance with 
chloroquine probably due to differences in the mode of 
action of compounds present in the extracts. This 
indicates that the extracts from these plants have the 
potential of solving the problem of multi-drug 
resistance. These plants warrant further detailed 
biological and chemical studies. The bioactive principles 
could be isolated from these plants and used to develop 
cheap anti-malarial drugs. C. myricoides has been also 
reported to be useful in the management of other 
parasitic diseases such as theileriosis (Baerts and 
Lehman, 1991; Muregi et al, 2004). Phytochemical 
investigations in the genus Clerodendrum has revealed 
macrocylic alkaloids (Muregi et al, 2004) triterpenoids 
saponins (Toyota et al, 1990) and iridoid glycosides 
(Calis et al, 1994) with no indications of their anti-
plasmodial activity. 
Ajuga methanolic extracts exhibiting reasonable anti-
plasmodial activity would be supported by previous 
bioassay guided phytochemical investigations that 
showed cardio tonic (Kuria and Muriuki, 1984) and 
anti-plasmodial activities due to presence of egosterols-
5, 8- peroxide (Kuria et al, 2002).  
 
Lack of in vitro anti-plasmodial activity on C. edulis and 
S. princeae may not necessarily imply the same in vivo 
since compounds may either act as prodrugs, febrifuges 
(fever is one of the symptoms associated with a 
complicated severe P. falciparum malaria) or immuno-
modulators (Muregi, 2004). Active compounds isolated 
were from the bark of Melia azedarach and Azadirachta 
indica which have been found to be antiplasmodial 
compounds (Khalid et al, 1989). The results showed 
that the methanol extracts of the species Clutia 
abyssinica, Asparagus racemosus and Clerodendrum 
myricoides commonly used by traditional healers and 
the people of Aldai Division of Nandi South District, 
Nandi County (Jeruto et al, 2008) for the treatment of 
malaria, exhibited the highest in vivo antiplasmodial 
activity. 
Rather low in-vitro antiplasmodial activity was 
recorded in the other plants despite the fact that they 
have been used as traditional antimalarials for 
centuries. One probable explanation of their popular 
use in the treatment of malaria could be that they may 
be useful in managing other manifestations associated 
with malaria rather than therapeutic (anti –parasitic) 
activity. These would include reducing fever, 
convulsions and headache and possibly even 
immunostimulatory effects (Rasoanaivo et al, 1998). 
Several synthetic molecules have been shown to restore 
CQ-sensitivity in resistant Plasmodium falciparum 
(Oduola et al, 1998). Little is known about the 
mechanism of the reversal of resistance by herbal 
remedies. Rasoanaivo et al. (1998) have investigated 
several medicinal plants used in association with 
chloroquine by local populations in Madagascar. They 
have shown that not only do the crude alkaloids 
significantly enhance the in vitro and in vivo chloroquine 
action but also the isolated compounds reverse 
resistance significantly. 
The chemo suppression data showed that parasite 
clearance was much more pronounced on the fourth 
day. This may be attributed to high drug concentration 
in the blood due to repeated dosing and the drug has 
gained access into the parasites and exhibiting its 
effects. 
5. Conclusion 
The antiplasmodial activity of the crude extracts of 
screened plants C. abbyssinica, A. racemosus and C. 
myricoides supports their ethnopharmacological use as 
antimalarials. 
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